With 2.73 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.71 million shares. The 52-week range on CLNE shows that it touched its highest point at $3.67 and its lowest point at $1.30 during that stretch. It currently has a 1-year price target of $5.92. Beta for the stock currently stands at 2.62.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CLNE was up-trending over the past week, with a rise of 3.90%, but this was up by 3.90% over a month. Three-month performance dropped to -53.08% while six-month performance fell -48.39%. The stock lost -32.49% in the past year, while it has lost -36.25% so far this year. A look at the trailing 12-month EPS for CLNE yields -0.89 with Next year EPS estimates of -0.23. For the next quarter, that number is -0.07. This implies an EPS growth rate of -1384.20% for this year and 41.38% for next year.
Float and Shares Shorts:
At present, 223.74 million CLNE shares are outstanding with a float of 162.45 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CLNE since 2 analysts follow the stock currently. There are 1 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.03067857 being high and -$0.00245429 being low. For CLNE, this leads to a yearly average estimate of $0.00859.
